QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
QQQ   379.12 (+0.31%)
AAPL   149.32 (+0.46%)
MSFT   310.11 (+0.64%)
FB   315.81 (-3.92%)
GOOGL   2,786.17 (+1.35%)
TSLA   1,018.43 (-0.63%)
AMZN   3,376.07 (+1.68%)
NVDA   247.17 (+6.70%)
BABA   169.99 (-3.51%)
NIO   40.47 (-1.94%)
CGC   13.17 (-2.95%)
GE   107.44 (+2.03%)
AMD   122.93 (+0.47%)
MU   68.94 (+0.26%)
T   25.37 (-1.05%)
F   15.94 (-0.38%)
ACB   7.03 (-2.09%)
DIS   172.04 (+0.02%)
PFE   43.56 (+0.95%)
BA   209.81 (-1.44%)
AMC   36.05 (-2.12%)
NASDAQ:LMNS

Lumenis Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive LMNS News and Ratings via Email

Sign-up to receive the latest news and ratings for Lumenis and its competitors with MarketBeat's FREE daily newsletter.


Lumenis logo

About Lumenis

Lumenis Ltd. (Lumenis) is a provider of energy-based, minimally invasive clinical solutions. The Company operates through three segments: surgical, ophthalmic and aesthetic. The Company offers energy-based solutions for medically necessary and elective procedures, primarily for the aging population. Its solutions include the holmium laser, the Lumenis Pulse 120H, used for urologic applications; the VersaPulse PowerSuite platform which uses holmium lasers for urologic applications; the M22 multi-energy, a multi-application platform for the treatment of various skin conditions, and the Selecta multi-modality platform for retinal, secondary cataract and glaucoma therapies. It offers products to hospitals, outpatient clinics, ambulatory surgery centers, physicians' offices, private clinics and aesthetic chains. Its locations include Yokneam, Israel, where surgical and aesthetic products are manufactured, and Salt Lake City, Utah, where ophthalmic products are manufactured.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Sector
N/A
Current Symbol
NASDAQ:LMNS
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.88 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Lumenis (NASDAQ:LMNS) Frequently Asked Questions

What stocks does MarketBeat like better than Lumenis?

Wall Street analysts have given Lumenis a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Lumenis wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Lumenis' earnings last quarter?

Lumenis Ltd. (NASDAQ:LMNS) issued its quarterly earnings data on Tuesday, May, 12th. The medical equipment provider reported $0.06 EPS for the quarter, missing the Zacks' consensus estimate of $0.11 by $0.05. The medical equipment provider earned $68.51 million during the quarter, compared to analyst estimates of $68.36 million. The business's revenue was up 4.1% compared to the same quarter last year. During the same quarter last year, the company posted $0.07 earnings per share.
View Lumenis' earnings history
.

Who are Lumenis' key executives?

Lumenis' management team includes the following people:
  • Harel Beit-On, Chairman of the Board (Age 52)
  • Zipora Ozer-Armon, Chief Executive Officer (Age 51)
  • Ophir Yakovian, Chief Financial Officer
  • Qiying Zhai, Senior Vice President and Regional President, Lumenis China
  • Eran Cohen, Vice President - Global Operations (Age 57)
  • Elad Benjamin, Vice President and General Manager - Surgical Strategic Business Unit
  • Hadas Padan, Vice President and General Manager Vision Strategic Business Unit
  • Roy Ramati, Vice President, General Manager - Aesthetic Strategic Business Unit
  • Kfir Azoulay, Vice President - Corporate Marketing
  • Ido Ben-Tov, Vice President - Service

What other stocks do shareholders of Lumenis own?

What is Lumenis' stock symbol?

Lumenis trades on the NASDAQ under the ticker symbol "LMNS."

What is Lumenis' official website?

The official website for Lumenis is www.lumenis.com.

Where are Lumenis' headquarters?

How can I contact Lumenis?

Lumenis' mailing address is Hakidma 6 Yokneam Industrial Park P.O.B. # 240, YOKNEAM, 2069204, Israel. The medical equipment provider can be reached via phone at +972-4-9599000.


This page was last updated on 10/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.